Explore

Trendline Trendline
MaaT Pharma Faces Regulatory Hurdle with Negative Trend Opinion for MaaT013 in Europe

MaaT Pharma Faces Regulatory Hurdle with Negative Trend Opinion for MaaT013 in Europe

MaaT Pharma Faces Regulatory Hurdle with Negative Trend Opinion for MaaT013 in Europe
Trendline Trendline
Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions

Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions

Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions
Trendline Trendline
FDA Accepts sNDA and Grants Priority Review to AQNEURSA for Ataxia-Telangiectasia

FDA Accepts sNDA and Grants Priority Review to AQNEURSA for Ataxia-Telangiectasia

FDA Accepts sNDA and Grants Priority Review to AQNEURSA for Ataxia-Telangiectasia
Trendline Trendline
Savara Presents Long-Term Data on Molgramostim for Rare Lung Disease at ATS Conference

Savara Presents Long-Term Data on Molgramostim for Rare Lung Disease at ATS Conference

Savara Presents Long-Term Data on Molgramostim for Rare Lung Disease at ATS Conference
Trendline Trendline
CEL-SCI Announces Key Developments in Multikine Cancer Treatment and Strategic Partnership

CEL-SCI Announces Key Developments in Multikine Cancer Treatment and Strategic Partnership

CEL-SCI Announces Key Developments in Multikine Cancer Treatment and Strategic Partnership
Trendline Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Trendline Trendline
Sanofi's Experimental Therapy for AATD Shows Promise in Phase 2 Trial

Sanofi's Experimental Therapy for AATD Shows Promise in Phase 2 Trial

Sanofi's Experimental Therapy for AATD Shows Promise in Phase 2 Trial
Trendline Trendline
Lantern Pharma's HARMONIC Trial Receives FDA Support for Protocol Amendments in NSCLC Treatment

Lantern Pharma's HARMONIC Trial Receives FDA Support for Protocol Amendments in NSCLC Treatment

Lantern Pharma's HARMONIC Trial Receives FDA Support for Protocol Amendments in NSCLC Treatment
Trendline Trendline
Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions

Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions

Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions
Trendline Trendline
IntraBio Begins Phase III Trial for CACNA1A-Related Disorders

IntraBio Begins Phase III Trial for CACNA1A-Related Disorders

IntraBio Begins Phase III Trial for CACNA1A-Related Disorders
Trendline Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Trendline Trendline
CEL-SCI Reports Progress in Multikine Cancer Therapy Development

CEL-SCI Reports Progress in Multikine Cancer Therapy Development

CEL-SCI Reports Progress in Multikine Cancer Therapy Development